A detailed history of First Pacific Financial transactions in Novavax Inc stock. As of the latest transaction made, First Pacific Financial holds 146 shares of NVAX stock, worth $1,017. This represents 0.0% of its overall portfolio holdings.

Number of Shares
146
Previous 146 -0.0%
Holding current value
$1,017
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 18, 2025

BUY
$5.43 - $7.74 $792 - $1,130
146 New
146 $0

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $545M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track First Pacific Financial Portfolio

Follow First Pacific Financial and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Pacific Financial, based on Form 13F filings with the SEC.

News

Stay updated on First Pacific Financial with notifications on news.